United States District Court: Levi Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Indiana on behalf of investors who purchased Endocyte, Inc. "Endocyte" or the "Company" /quotes/zigman/119422/delayed /quotes/nls/ecyt 1.05% common stock between March 21, 2014 and May 2, 2014. , according to Market Watch. The complaint alleges that throughout the Class Period defendants issued misleading statements regarding the efficacy of the Company experimental drug and misrepresented and/or failed to disclose material information regarding the Company business and financial prospects. In particular it is alleged that Endocyte misrepresented the nature of positive statements made about the drug in a March 21 press release, ultimately capitalizing on the resulting stock price increase to issue a public offering and sell shares at an inflated price. NEW Aug 13, 2014 via - For more information, click here: http://zlk.9nl.com/endocyte-ecyt .
(news.financializer.com). As
reported in the news.
Tagged under Southern District of Indiana, the Company topics.